CN1152916A - 三氟甲基喹啉羧酸衍生物 - Google Patents

三氟甲基喹啉羧酸衍生物 Download PDF

Info

Publication number
CN1152916A
CN1152916A CN95194136A CN95194136A CN1152916A CN 1152916 A CN1152916 A CN 1152916A CN 95194136 A CN95194136 A CN 95194136A CN 95194136 A CN95194136 A CN 95194136A CN 1152916 A CN1152916 A CN 1152916A
Authority
CN
China
Prior art keywords
carboxylic acid
group
pharmaceutically acceptable
ester
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95194136A
Other languages
English (en)
Chinese (zh)
Inventor
木村富美夫
胜部哲嗣
西垣隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Ube Corp
Original Assignee
Sankyo Co Ltd
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd, Ube Industries Ltd filed Critical Sankyo Co Ltd
Publication of CN1152916A publication Critical patent/CN1152916A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN95194136A 1994-07-18 1995-06-07 三氟甲基喹啉羧酸衍生物 Pending CN1152916A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16512694 1994-07-18
JP165126/94 1994-07-18

Publications (1)

Publication Number Publication Date
CN1152916A true CN1152916A (zh) 1997-06-25

Family

ID=15806410

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95194136A Pending CN1152916A (zh) 1994-07-18 1995-06-07 三氟甲基喹啉羧酸衍生物

Country Status (14)

Country Link
US (1) US6034086A (cs)
EP (1) EP0773214A4 (cs)
KR (1) KR970704693A (cs)
CN (1) CN1152916A (cs)
AU (1) AU683569B2 (cs)
CA (1) CA2194435A1 (cs)
CZ (1) CZ12097A3 (cs)
FI (1) FI970195L (cs)
HU (1) HUT76643A (cs)
MX (1) MX9700497A (cs)
NO (1) NO307704B1 (cs)
NZ (1) NZ287550A (cs)
RU (1) RU2140919C1 (cs)
WO (1) WO1996002512A1 (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115466212A (zh) * 2022-10-26 2022-12-13 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046115A1 (ja) * 2002-11-20 2004-06-03 Japan Tobacco Inc. ４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
WO2005113509A1 (en) * 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
WO2006109661A1 (ja) 2005-04-06 2006-10-19 Chugai Seiyaku Kabushiki Kaisha ２，３，４－トリフルオロ－５－（ヨード又はブロモ）安息香酸の製造方法
KR101023635B1 (ko) * 2006-03-06 2011-03-22 니뽄 다바코 산교 가부시키가이샤 4-옥소퀴놀린 화합물 제조 방법
DE102006017701A1 (de) * 2006-04-15 2007-10-25 Degussa Gmbh Silicium-Titan-Mischoxidpulver, Dispersion hiervon und daraus hergestellter titanhaltiger Zeolith
DE102006017700A1 (de) * 2006-04-15 2007-10-25 Degussa Gmbh Silicium-Titan-Mischoxid enthaltende Dispersion zur Herstellung titanhaltiger Zeolithe

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420770A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
EP0470252A4 (en) * 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
HU205717B (en) * 1989-04-28 1992-06-29 Daiichi Seiyaku Co Process for producing pharmaceutical composition against human immunodeficiency, comprising pyridionecarboxylic acid derivative
DE69132348T2 (de) * 1990-05-02 2001-03-15 Abbott Laboratories, Abbott Park Verbindungen vom chinolizinon-typ
US5221676A (en) * 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JPH09503783A (ja) * 1993-10-14 1997-04-15 アボツト・ラボラトリーズ キノリジノン型化合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115466212A (zh) * 2022-10-26 2022-12-13 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用

Also Published As

Publication number Publication date
AU683569B2 (en) 1997-11-13
FI970195A7 (fi) 1997-02-05
HU9700148D0 (en) 1997-03-28
AU2629295A (en) 1996-02-16
RU2140919C1 (ru) 1999-11-10
EP0773214A1 (en) 1997-05-14
NO307704B1 (no) 2000-05-15
FI970195A0 (fi) 1997-01-17
KR970704693A (ko) 1997-09-06
CZ12097A3 (en) 1997-09-17
NO970144L (no) 1997-01-20
US6034086A (en) 2000-03-07
HUT76643A (en) 1997-10-28
WO1996002512A1 (en) 1996-02-01
NZ287550A (en) 1998-01-26
EP0773214A4 (en) 1998-04-15
MX9700497A (es) 1997-04-30
CA2194435A1 (en) 1996-02-01
FI970195L (fi) 1997-02-05
NO970144D0 (no) 1997-01-14

Similar Documents

Publication Publication Date Title
CN1040106C (zh) 哌嗪衍生物的制备方法
AU2010258295B2 (en) Compounds useful for treating AIDS
RU2124510C1 (ru) Производные аминохинолона, замещенные фенильной или гетероароматической группой
CN1247567C (zh) 2－氨基－3－烷基嘧啶酮衍生物作为GSK3β抑制剂
CN1120156C (zh) N,n′－二(喹啉－4－基)－二胺衍生物、其制备及作为抗疟药的应用
CN1015057B (zh) 哌嗪基-杂环化合物的制备方法
CN1860106A (zh) 用作蛋白激酶抑制剂的化合物和组合物
CN1639164A (zh) 含氮杂环化合物
WO2012008564A1 (ja) 含窒素芳香族複素環誘導体
WO2012008563A1 (ja) 含窒素芳香族複素環誘導体
CN1129941A (zh) 取代的氮杂二氢亚吲哚基化合物及其制备方法
CN87101731A (zh) 8号位上取代的喹诺酮羧酸衍生物及其制备方法
CN1753874A (zh) 可用作肾上腺素受体激动剂的 5－′( r )－2－( 5 , 6－二乙基－茚满－2－基氨基)－1－羟基－乙基－8－羟基－(1h)－喹啉－2－酮盐的制备方法
CN1133840A (zh) 吲哚哌啶衍生物
JPH0853447A (ja) 新規１，３−ジヒドロ−２Ｈ−ピロロ〔２，３−ｂ〕ピリジン−２−オンとオキサゾロ〔４，５−ｂ〕ピリジン−２（３Ｈ）−オン化合物、その製造方法及びそれらを含む薬剤組成物
CN1247584C (zh) 1－[烷基]、1－[(杂芳基)烷基]和1－[(芳基)烷基]－7－吡啶基－咪唑并[1,2－a]嘧啶－5(1H)－酮衍生物
CN1299357A (zh) 主要用于治疗骨质疏松的吲哚衍生物
JP5565841B2 (ja) キノリン誘導体とチロシンキナーゼ阻害剤としてのその使用
HUT76643A (en) Trifluoromethylquinolinecarboxylic acid derivative, pharmaceutical compositions containing them and their use
JP2930539B2 (ja) トリフルオロメチルキノリンカルボン酸誘導体
CN1370172A (zh) 光学活性的吡咯并哒嗪化合物
HK1042704A1 (en) Semi-hydrochloride of 8-cyan-1-cyclopropyl -7-(1s,6s-2,8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro -4-oxo-3- quinoline carboxylic acid
CN1198821C (zh) 磺酰胺衍生物的制备方法及其晶体
CN1798734A (zh) 作为蛋白激酶抑制剂的新化合物和组合物
CN1733764A (zh) 3－位取代的萘啶酮类化合物及其制备方法和在制药中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned